Saiag E, Gamzu R, Padova H, Paran Y, Goldiner I, Cohen N
J Clin Med. 2024; 13(21).
PMID: 39518677
PMC: 11546691.
DOI: 10.3390/jcm13216538.
Nejhaddadgar N, Jafarzadeh M, Khazir Z, Yoosefi Lebni J, Rostami M, Janjani P
Health Sci Rep. 2023; 6(8):e1494.
PMID: 37621386
PMC: 10444984.
DOI: 10.1002/hsr2.1494.
Szabo E, Modok S, Ronaszeki B, Farago A, Gemes N, Nagy L
Front Med (Lausanne). 2023; 10:1176168.
PMID: 37529238
PMC: 10389666.
DOI: 10.3389/fmed.2023.1176168.
Galanis P, Vraka I, Katsiroumpa A, Siskou O, Konstantakopoulou O, Katsoulas T
J Clin Nurs. 2022; 32(13-14):3943-3953.
PMID: 36345133
PMC: 9878136.
DOI: 10.1111/jocn.16576.
Hussein K, Dabaja-Younis H, Szwarcwort-Cohen M, Almog R, Leiba R, Weissman A
Vaccines (Basel). 2022; 10(10).
PMID: 36298606
PMC: 9607254.
DOI: 10.3390/vaccines10101741.
Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients.
Honfi D, Gemes N, Szabo E, Neuperger P, Balog J, Nagy L
Int J Mol Sci. 2022; 23(19).
PMID: 36232710
PMC: 9569441.
DOI: 10.3390/ijms231911411.
Anti-SARS-CoV-2 antibody levels after four BNT162b2 vaccine doses among health-care workers.
Saiag E, Marudi O, Cohen N, Goldiner I, Ben-Ami R, Sprecher E
Travel Med Infect Dis. 2022; 50:102429.
PMID: 35987513
PMC: 9381422.
DOI: 10.1016/j.tmaid.2022.102429.
SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies.
Terpos E, Fotiou D, Karalis V, Ntanasis-Stathopoulos I, Sklirou A, Gavriatopoulou M
Am J Hematol. 2022; 97(10):1300-1308.
PMID: 35871310
PMC: 9349831.
DOI: 10.1002/ajh.26669.
Immunogenicity and Reactogenicity of the Booster Dose of COVID-19 Vaccines and Related Factors: A Panel Study from the General Population in Serbia.
Stosic M, Milic M, Markovic M, Kelic I, Bukumiric Z, Veljkovic M
Vaccines (Basel). 2022; 10(6).
PMID: 35746446
PMC: 9228276.
DOI: 10.3390/vaccines10060838.
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.
Szebeni G, Gemes N, Honfi D, Szabo E, Neuperger P, Balog J
Front Immunol. 2022; 13:846248.
PMID: 35432314
PMC: 9008200.
DOI: 10.3389/fimmu.2022.846248.
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques.
Dalvie N, Tostanoski L, Rodriguez-Aponte S, Kaur K, Bajoria S, Kumru O
Sci Adv. 2022; 8(11):eabl6015.
PMID: 35294244
PMC: 8926328.
DOI: 10.1126/sciadv.abl6015.
Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected.
Tre-Hardy M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, Coman-Vlagea N, Della Vecchia A
J Infect. 2022; 84(4):e31-e33.
PMID: 35181372
PMC: 8847092.
DOI: 10.1016/j.jinf.2022.02.009.
Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19.
Dundar B, Karahangil K, Elgormus C, Topsakal H
J Med Virol. 2022; 94(6):2431-2437.
PMID: 35128700
PMC: 9088406.
DOI: 10.1002/jmv.27649.
Attitudes of Poles towards the COVID-19 Vaccine Booster Dose: An Online Survey in Poland.
Babicki M, Mastalerz-Migas A
Vaccines (Basel). 2022; 10(1).
PMID: 35062729
PMC: 8778409.
DOI: 10.3390/vaccines10010068.
Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy.
Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P
Blood. 2022; 139(9):1409-1412.
PMID: 34986251
PMC: 8736278.
DOI: 10.1182/blood.2021014989.
Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population.
Weinberger B
Vaccines (Basel). 2021; 9(12).
PMID: 34960181
PMC: 8704374.
DOI: 10.3390/vaccines9121435.
Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer.
Ligumsky H, Dor H, Etan T, Golomb I, Nikolaevski-Berlin A, Greenberg I
Lancet Oncol. 2021; 23(2):193-195.
PMID: 34953523
PMC: 8700280.
DOI: 10.1016/S1470-2045(21)00715-4.
